Inhalant Powder

Known as: Powdered Dose Inhaler, Inhalant Powder Dose Form, Inhalant Powder Dosage Form 
Powdered medication inhaled as a measured dose.

Topic mentions per year

Topic mentions per year

1982-2018
05101519822018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Background: Medications for respiratory disorders including asthma and chronic obstructive pulmonary disease (COPD) are typically… (More)
  • table 1
  • table 2
  • table 2
  • table 3
  • table 4
Is this relevant?
2013
2013
BACKGROUND Medications for respiratory disorders including asthma and chronic obstructive pulmonary disease (COPD) are typically… (More)
  • table 1
  • table 2
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND A light-porous-particle, dry-powder formulation of tobramycin was developed, using PulmoSphere® technology, to improve… (More)
  • figure 1
  • table 2
  • table 1
  • figure 2
  • table 3
Is this relevant?
2011
2011
Tobramycin inhalation solution is used to treat chronic Pseudomonas aeruginosa lung infection in cystic fibrosis (CF) patients… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2011
2011
To determine distribution and deposition of Technosphere® Insulin (TI) inhalation powder and the rate of clearance of fumaryl… (More)
  • figure 1
  • figure 2
  • table I
  • table II
  • figure 5
Is this relevant?
2009
2009
Pitrakinra, a 15-kDa recombinant human interleukin-4 mutein, targets allergic Th2 inflammation by competitively binding to… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Aerosolized antibiotics are associated with a high treatment burden that can result in non-adherence to chronic therapy. We… (More)
Is this relevant?
2006
2006
The efficacy and safety of human insulin inhalation powder (HIIP) plus insulin glargine were compared to subcutaneously injected… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2005
2005
OBJECTIVE To evaluate efficacy, safety, health outcomes, and cost-effectiveness of fluticasone propionate (FP) versus montelukast… (More)
Is this relevant?
2001
2001
BACKGROUND The incidence of pediatric asthma has increased dramatically over the past few decades, with approximately 5% of… (More)
Is this relevant?